Efficacy and safety of adalimumab every other week versus methotrexate once weekly in children and adolescents with severe chronic plaque psoriasis: a randomised, double-blind, phase 3 trial - Concepedia

Concepedia

Publication | Closed Access

Efficacy and safety of adalimumab every other week versus methotrexate once weekly in children and adolescents with severe chronic plaque psoriasis: a randomised, double-blind, phase 3 trial

147

Citations

18

References

2017

Year

Kim Papp, Diamant Thaçi, Danielle Marcoux, Lisa Weibel, Sandra Philipp, Pierre‐Dominique Ghislain, Ian Landells, Peter H. Hoeger, Carol Kotkin, Kristina Unnebrink,

Systemic TreatmentClinical TrialsPediatricsClinical DermatologyPharmacotherapyDermatologyMedicine

References

	Year	Citations

Page 1